Back to results
US 11,680,265 B2Granted
Genome editing using effector oligonucleotides for therapeutic treatment
AssigneeResearch Foundation to Cure AIDS, Inc.
InventorKambiz Shekdar
Life of this patent
Estimating the term…
Abstract
The invention provides compositions and methods of making and using effector oligonucleotides, including effector oligonucleotides with greater than one mismatch as compared to its target sequence. These effector oligonucleotides are useful for improving the efficiency of genomic editing as well as providing therapeutic benefits to individuals in need thereof.
Claims13
An effector oligonucleotide comprising a sequence selected from the group consisting of SEQ ID NO:5, SEQ ID NO:7, SEQ ID NO:9, and SEQ ID NO:11.
Dependencies are inferred from the claim text.